1-1 of 1
Radu Bucur Gologan, MD, PhD
Close
Sort by
Journal Articles

Hypolipemiant besides Antileukemic Effect of Imatinib Mesylate (Case Report).

Radu Bucur Gologan, MD, PhD, Gabriela Constantinescu, MD, Daniela Georgescu, MD, Daniela Ostroveanu, MD,PhD, Didona Vasilache, MD, Camelia Dobrea, MD, Daniela Iancu, MD, Viola Popov, MD
Journal: Blood
Blood (2006) 108 (11): 4832.
https://doi.org/10.1182/blood.V108.11.4832.4832
Published: 2006